MedPath

The Improvement of Black Raspberry in Obese and Mild AZ Patients Infected With H. Pylori

Not Applicable
Completed
Conditions
Alzheimer Disease
H Pylori Infection
Interventions
Dietary Supplement: Black raspberry
Other: Placebo
Registration Number
NCT05680532
Lead Sponsor
Chung Shan Medical University
Brief Summary

The current study was designed to check the impact of black raspberry (BR) on obese and mild Alzheimers (AZ) patients infected with Helicobacter pylori (H pylori). Through checking various parameters including anthropometric, antioxidants, and CDR.

Detailed Description

The current study was designed to check the impact of black raspberry (BR) on obese and mild Alzheimers (AZ) patients infected with Helicobacter pylori (H pylori).

Preclinical studies (In vitro model) were conducted using 3T3-L1 adipocyte cells to check the anti-adhesion activity of BR.

For the clinical trial, a total of 21 obese mild AZ patients were recruited and separated into 2 groups: Experimental (BR group) and Placebo group.

Experimental group and Placebo group subjects were requested to take either 50 g of BR or 50 g of dextrin respectively for 4 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • BMI ≧ 27, Waist circumference: men ≧ 90cm, women ≧ 80cm,
  • Body fat: male ≧ 25%, female ≧ 30%,
  • UBT 13C test value> 10‰ (H. pylori (+)),
  • CDR (clinical dementia rating) = 0.5
Exclusion Criteria
  • BMI< 27
  • Severe chronic diseases (liver disease, cardiovascular disease, kidney disease)
  • Alcohol abuse
  • Smoking habit
  • Taking berry-related supplementation or any known allergies related to berries.
  • Subjects with prior history of H. pylori infection were treated with triple therapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BR groupBlack raspberryExperimental group AZ subjects were requested to take 50 g of BR powder dissolved in 240 ml of water for 4 weeks.
Placebo groupPlaceboPlacebo group AZ subjects were requested to take 50 g of dextrin powder dissolved in 240 ml of water for 4 weeks.
Primary Outcome Measures
NameTimeMethod
Glycemic indices8 weeks

No significant changes in any of the glycemic indices

Anthropometric parameters8 weeks

BMI were significantly altered

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chung Shan Medical University

🇨🇳

Taichung city, Taichung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath